{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:33:46Z","timestamp":1778740426370,"version":"3.51.4"},"reference-count":200,"publisher":"Elsevier","isbn-type":[{"value":"9780443473364","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003086","name":"Eusko Jaurlaritza","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2023\\u2013150479NB-I00"],"award-info":[{"award-number":["PID2023\\u2013150479NB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.adgen.2025.11.008","type":"book-chapter","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T12:51:08Z","timestamp":1764593468000},"page":"229-278","source":"Crossref","is-referenced-by-count":1,"title":["The JAK-STAT signaling pathway in inflammatory and autoimmune diseases: Its potential role as a therapeutic target"],"prefix":"10.1016","member":"78","reference":[{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib1","doi-asserted-by":"crossref","DOI":"10.1186\/s43141-021-00214-2","article-title":"Assessing the association of rs7574865 STAT4 gene variant and type 1 diabetes mellitus among Egyptian patients","volume":"19","author":"Abdelmajed","year":"2021","journal-title":"Journal of Genetic Engineering and Biotechnology"},{"issue":"6","key":"10.1016\/bs.adgen.2025.11.008_bib2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/ni794","article-title":"T-Bet is a STAT1-induced regulator of IL-12R expression in na\u00efve CD4+ T cells","volume":"3","author":"Afkarian","year":"2002","journal-title":"Nature Immunology"},{"issue":"26","key":"10.1016\/bs.adgen.2025.11.008_bib3","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.2174\/1381612829666230904150808","article-title":"Role of Th17 and IL-17 cytokines on inflammatory and auto-immune diseases","volume":"29","author":"Akhter","year":"2023","journal-title":"Current Pharmaceutical Design"},{"issue":"2","key":"10.1016\/bs.adgen.2025.11.008_bib4","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2024.2390705","article-title":"Epithelial barrier dysfunction and microbial dysbiosis: Exploring the pathogenesis and therapeutic strategies for Crohn\u2019s disease","volume":"13","author":"Akko\u00e7","year":"2025","journal-title":"Tissue Barriers"},{"issue":"12","key":"10.1016\/bs.adgen.2025.11.008_bib5","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.immuni.2022.11.009","article-title":"The pathogenesis of rheumatoid arthritis","volume":"55","author":"Alivernini","year":"2022","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40744-020-00258-9","article-title":"Update on the safety profile of tofacitinib in rheumatoid arthritis from clinical trials to real-world studies: A narrative review","volume":"8","author":"\u00c1lvaro-Gracia","year":"2021","journal-title":"Rheumatology and Therapy"},{"key":"10.1016\/bs.adgen.2025.11.008_bib7","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.30330","article-title":"An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management","author":"Ameer","year":"2022","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/bs.adgen.2025.11.008_bib8","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/jamadermatol.2024.2701","article-title":"Tyrosine kinase 2 inhibition with zasocitinib (TAK-279) in psoriasis","volume":"160","author":"Armstrong","year":"2024","journal-title":"JAMA Dermatology"},{"key":"10.1016\/bs.adgen.2025.11.008_bib9","first-page":"1349","article-title":"Role of JAK2\/STAT3 signaling pathway in the tumorigenesis, chemotherapy resistance, and treatment of solid tumors: A systemic review","author":"Ayele","year":"2022"},{"issue":"16","key":"10.1016\/bs.adgen.2025.11.008_bib10","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.1073\/pnas.92.16.7307","article-title":"Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes","volume":"92","author":"Bacon","year":"1995","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"10","key":"10.1016\/bs.adgen.2025.11.008_bib11","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/ejhg.2009.41","article-title":"Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor","volume":"17","author":"Ban","year":"2009","journal-title":"European Journal of Human Genetics"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s42003-021-01846-3","article-title":"Endothelial Jak3 expression enhances pro-hematopoietic angiocrine function in mice","volume":"4","author":"Barcia Dur\u00e1n","year":"2021","journal-title":"Communications Biology"},{"issue":"6","key":"10.1016\/bs.adgen.2025.11.008_bib13","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.381","article-title":"Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes","volume":"41","author":"Barrett","year":"2009","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.adgen.2025.11.008_bib14","series-title":"Receptor tyrosine kinases in neurodegenerative and psychiatric disorders","first-page":"117","article-title":"Chapter 4 - Receptor tyrosine kinases (RTKs): From biology to pathophysiology","author":"Batool","year":"2023"},{"issue":"10","key":"10.1016\/bs.adgen.2025.11.008_bib15","doi-asserted-by":"crossref","DOI":"10.4103\/jfmpc.jfmpc_112_24","article-title":"JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician","volume":"13","author":"Beard","year":"2024","journal-title":"Journal of Family Medicine and Primary Care"},{"issue":"11","key":"10.1016\/bs.adgen.2025.11.008_bib16","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/ng.2770","article-title":"Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis","volume":"45","author":"Beecham","year":"2013","journal-title":"Nature Genetics"},{"issue":"3","key":"10.1016\/bs.adgen.2025.11.008_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/tan.12057","article-title":"Association study of STAT4 polymorphisms and type 1 diabetes in Northeastern Chinese Han population","volume":"81","author":"Bi","year":"2013","journal-title":"Tissue Antigens"},{"issue":"14","key":"10.1016\/bs.adgen.2025.11.008_bib18","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s40265-023-01928-y","article-title":"Ritlecitinib: First approval","volume":"83","author":"Blair","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/bs.adgen.2025.11.008_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2025.05.1053","article-title":"Highly selective, allosteric inhibition of TYK2 with oral ESK-001 in patients with moderate-to-severe plaque psoriasis: Results from STRIDE, a 12-week, randomized, double-blinded, placebo-controlled, dose-ranging phase 2 study","author":"Blauvelt","year":"2025","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"9","key":"10.1016\/bs.adgen.2025.11.008_bib20","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/intimm\/dxh293","article-title":"Stat4-null non-obese diabetic mice: Protection from diabetes and experimental allergic encephalomyelitis, but with concomitant epitope spread","volume":"17","author":"Boyton","year":"2005","journal-title":"International Immunology"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib21","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.190221","article-title":"A practical view of fine-mapping and gene prioritization in the post-genome-wide association era","volume":"10","author":"Broekema","year":"2020","journal-title":"Open Biol."},{"issue":"7145","key":"10.1016\/bs.adgen.2025.11.008_bib22","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05911","article-title":"Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls","volume":"447","author":"Burton","year":"2007","journal-title":"Nature"},{"issue":"35","key":"10.1016\/bs.adgen.2025.11.008_bib23","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.3748\/wjg.v30.i35.3942","article-title":"Game changer: How Janus kinase inhibitors are reshaping the landscape of ulcerative colitis management","volume":"30","author":"Caballero-Mateos","year":"2024","journal-title":"World Journal of Gastroenterology"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116636","article-title":"JAK2 Exon 14 skipping in patients with primary myelofibrosis: A minor splice variant modulated by the JAK2-V617F allele burden","volume":"10","author":"Catarsi","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/cts.13435","article-title":"First\u2010in\u2010human study of deucravacitinib: A selective, potent, allosteric small\u2010moleculem inhibitor of tyrosine kinase 2","volume":"16","author":"Catlett","year":"2023","journal-title":"Clinical and Translational Science"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib26","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.1038\/s41467-022-34069-z","article-title":"The type 1 diabetes gene TYK2 regulates \u03b2-cell development and its responses to interferon-\u03b1","volume":"13","author":"Chandra","year":"2022","journal-title":"Nature Communications"},{"issue":"11","key":"10.1016\/bs.adgen.2025.11.008_bib27","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/1346-8138.16116","article-title":"Safety considerations of systemic Janus kinase inhibitors in atopic dermatitis applications","volume":"48","author":"Chang","year":"2021","journal-title":"The Journal of Dermatology"},{"issue":"5","key":"10.1016\/bs.adgen.2025.11.008_bib28","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.drudis.2017.01.013","article-title":"Safety of antisense oligonucleotide and siRNA-based therapeutics","volume":"22","author":"Chi","year":"2017","journal-title":"Drug Discovery Today"},{"issue":"2","key":"10.1016\/bs.adgen.2025.11.008_bib29","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/ecco-jcc\/jjab129","article-title":"Therapeutic siRNAs targeting the JAK\/STAT signalling pathway in inflammatory bowel diseases","volume":"16","author":"Cl\u00e9ment","year":"2022","journal-title":"Journal of Crohn\u2019s and Colitis"},{"issue":"12","key":"10.1016\/bs.adgen.2025.11.008_bib30","first-page":"8133","article-title":"Direct binding to and tyrosine phosphorylation of the a subunit of the type I interferon receptor by p135 tyrosine kinase","volume":"14","author":"Colamonici","year":"1994","journal-title":"Molecular and Cellular Biology"},{"issue":"2","key":"10.1016\/bs.adgen.2025.11.008_bib31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ejhg.2015.87","article-title":"Common polygenic variation in coeliac disease and confirmation of ZNF335 and NIFA as disease susceptibility loci","volume":"24","author":"Coleman","year":"2016","journal-title":"European Journal of Human Genetics"},{"key":"10.1016\/bs.adgen.2025.11.008_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1245535","article-title":"Recent advances in JAK inhibitors for the treatment of metabolic syndrome","volume":"14","author":"Collotta","year":"2023","journal-title":"Frontiers in Pharmacology"},{"issue":"12","key":"10.1016\/bs.adgen.2025.11.008_bib33","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/ng.249","article-title":"Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci","volume":"40","author":"Cooper","year":"2008","journal-title":"Nature Genetics"},{"issue":"6","key":"10.1016\/bs.adgen.2025.11.008_bib34","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/ibd\/izaa280","article-title":"Impaired IFN-\u03b3-dependent STAT3 activation is associated with dysregulation of regulatory and inflammatory signaling in monocytes of ulcerative colitis patients","volume":"27","author":"Cordes","year":"2021","journal-title":"Inflammatory Bowel Diseases"},{"issue":"3","key":"10.1016\/bs.adgen.2025.11.008_bib35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/brain\/awr010","article-title":"Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility","volume":"134","author":"Couturier","year":"2011","journal-title":"Brain"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/gepi.22608","article-title":"Bayesian effect size ranking to prioritise genetic risk variants in common diseases for follow-up studies","volume":"49","author":"Crouch","year":"2025","journal-title":"Genetic Epidemiology"},{"issue":"3","key":"10.1016\/bs.adgen.2025.11.008_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00035-19","article-title":"Infectious complications of biological and small molecule targeted immunomodulatory therapies","volume":"33","author":"Davis","year":"2020","journal-title":"Clinical Microbiology Reviews"},{"issue":"4","key":"10.1016\/bs.adgen.2025.11.008_bib38","doi-asserted-by":"crossref","first-page":"17730","DOI":"10.4238\/2015.December.21.46","article-title":"Meta-analysis of STAT4 and IFIH1 polymorphisms in type 1 diabetes mellitus patients with autoimmune polyglandular syndrome type III","volume":"14","author":"de Azev\u00eado Silva","year":"2015","journal-title":"Genetics and Molecular Research"},{"key":"10.1016\/bs.adgen.2025.11.008_bib39","series-title":"Jak-inhibitors in dermatology","first-page":"131","article-title":"Safety, toxicity profile and side effects","author":"Demirci Saadet","year":"2025"},{"key":"10.1016\/bs.adgen.2025.11.008_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.942053","article-title":"JAK2 alterations in acute lymphoblastic leukemia: Molecular insights for superior precision medicine strategies","volume":"10","author":"Downes","year":"2022","journal-title":"Frontiers in cell and developmental biology"},{"issue":"4","key":"10.1016\/bs.adgen.2025.11.008_bib41","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ng.543","article-title":"Multiple common variants for celiac disease influencing immune gene expression","volume":"42","author":"Dubois","year":"2010","journal-title":"Nature Genetics"},{"issue":"5","key":"10.1016\/bs.adgen.2025.11.008_bib42","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1212\/WNL.0b013e3182616fc4","article-title":"Exome sequencing identifies a novel multiple sclerosis susceptibility variant in the TYK2 gene","volume":"79","author":"Dyment","year":"2012","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/bs.adgen.2025.11.008_bib43","first-page":"1485","article-title":"Pharmacology of inhibitors of Janus kinases \u2013 Part 1: Pharmacokinetics","volume":"20","author":"Eichner","year":"2022","journal-title":"JDDG: Journal Der Deutschen Dermatologischen Gesellschaft"},{"issue":"4","key":"10.1016\/bs.adgen.2025.11.008_bib44","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2009.21","article-title":"The role of inflammation in insulitis and \u03b2-cell loss in type 1 diabetes","volume":"5","author":"Eizirik","year":"2009","journal-title":"Nature Reviews Endocrinology"},{"issue":"4","key":"10.1016\/bs.adgen.2025.11.008_bib45","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2337\/db21-0443","article-title":"PTPN2 regulates the interferon signaling and endoplasmic reticulum stress response in pancreatic \u03b2-cells in autoimmune diabetes","volume":"71","author":"Elvira","year":"2022","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/bs.adgen.2025.11.008_bib46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/107327489800500207","article-title":"Antisense oligodeoxynucleotide technology: Potential use for the treatment of malignant brain tumors","volume":"5","author":"Engelhard","year":"1998","journal-title":"Cancer Control: Journal of the Moffitt Cancer Center"},{"issue":"4","key":"10.1016\/bs.adgen.2025.11.008_bib47","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00251-010-0500-x","article-title":"A polymorphism in PTPN2 gene is associated with an earlier onset of type 1 diabetes","volume":"63","author":"Espino-Paisan","year":"2011","journal-title":"Immunogenetics"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib48","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5114\/ceji.2019.92492","article-title":"STAT4 sequence variant and elevated gene expression are associated with type 1 diabetes in Polish children","volume":"45","author":"Fichna","year":"2020","journal-title":"Central European Journal Of\u00a0Immunology"},{"key":"10.1016\/bs.adgen.2025.11.008_bib49","doi-asserted-by":"crossref","unstructured":"Finn, C.M., Dhume, K., Prokop, E., Strutt, T.M., & McKinstry, K.K. STAT1 controls the functionality of influenza-primed CD4 T cells but therapeutic STAT4 engagement maximizes their antiviral impact. The Journal of Immunology 210(9):1292-1304. https:\/\/doi.org\/10.4049\/jimmunol.2200407.","DOI":"10.4049\/jimmunol.2200407"},{"issue":"2","key":"10.1016\/bs.adgen.2025.11.008_bib50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/path.1711650203","article-title":"Insulitis in type 1 (insulin-dependent) diabetes mellitus in man\u2014macrophages, lymphocytes, and interferon-\u03b3 containing cells","volume":"165","author":"Foulis","year":"1991","journal-title":"The Journal of Pathology"},{"issue":"9","key":"10.1016\/bs.adgen.2025.11.008_bib51","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s40265-023-01873-w","article-title":"Baricitinib for the treatment of alopecia areata","volume":"83","author":"Freitas","year":"2023","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/bs.adgen.2025.11.008_bib52","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/jnr.20995","article-title":"pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity","volume":"84","author":"Frisullo","year":"2006","journal-title":"Journal of Neuroscience Research"},{"issue":"2","key":"10.1016\/bs.adgen.2025.11.008_bib53","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/gene.2008.99","article-title":"Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23\/TNFAIP3 as a susceptibility locus","volume":"10","author":"Fung","year":"2009","journal-title":"Genes & Immunity"},{"issue":"9","key":"10.1016\/bs.adgen.2025.11.008_bib54","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.3390\/ijms25094681","article-title":"Inhibition of the JAK-STAT pathway in the treatment of psoriasis: A review of the literature","volume":"25","author":"Furtunescu","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"12","key":"10.1016\/bs.adgen.2025.11.008_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210290","article-title":"JAK\/STAT as a potential therapeutic target for osteolytic diseases","volume":"24","author":"Godoi","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.adgen.2025.11.008_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.754116","article-title":"A scoping review on use of drugs targeting the JAK\/STAT pathway in psoriasis","volume":"9","author":"G\u00f3mez-Garc\u00eda","year":"2022","journal-title":"Frontiers in Medicine"},{"key":"10.1016\/bs.adgen.2025.11.008_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.886736","article-title":"Functional impact of risk gene variants on the autoimmune responses in type 1 diabetes","volume":"13","author":"Gootjes","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.adgen.2025.11.008_bib58","article-title":"The TYK2-P1104A autoimmune protective variant limits coordinate signals required to generate specialized T cell subsets","volume":"10-2019","author":"Gorman","year":"2019","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib59","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/hmg\/ddv455","article-title":"Functional implications of disease-specific variants in loci jointly associated with coeliac disease and rheumatoid arthritis","volume":"25","author":"Gutierrez-Achury","year":"2016","journal-title":"Human Molecular Genetics"},{"issue":"2","key":"10.1016\/bs.adgen.2025.11.008_bib60","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/toxsci\/kfac002","article-title":"Gut-selective design of orally administered izencitinib (TD-1473) limits systemic exposure and effects of janus kinase inhibition in nonclinical species","volume":"186","author":"Hardwick","year":"2022","journal-title":"Toxicological Sciences"},{"key":"10.1016\/bs.adgen.2025.11.008_bib61","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.cyto.2017.10.022","article-title":"STAT5a and STAT6 gene expression levels in multiple sclerosis patients","volume":"106","author":"Hatami","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/bs.adgen.2025.11.008_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/s41574-025-01128-6","article-title":"Type 1 diabetes mellitus prevention: Present and future","author":"Henriques","year":"2025","journal-title":"Nature Reviews Endocrinology"},{"issue":"14","key":"10.1016\/bs.adgen.2025.11.008_bib63","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1242\/jcs.110.14.1543","article-title":"The mouse transcription factor Stat4 is expressed in haploid male germ cells and is present in the perinuclear theca of spermatozoa","volume":"110","author":"Herrada","year":"1997","journal-title":"Journal of Cell Science"},{"issue":"7","key":"10.1016\/bs.adgen.2025.11.008_bib64","article-title":"The role of autoimmune processes in demyelinating diseases of the nervous system: Focus on multiple sclerosis","volume":"19","author":"Hladkykh","year":"2023","journal-title":"International Neurological Journal (Ukraine)"},{"issue":"16","key":"10.1016\/bs.adgen.2025.11.008_bib65","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1093\/emboj\/cdg393","article-title":"Distinct requirements for the naturally occurring splice forms Stat4 and Stat4 in IL-12 responses","volume":"22","author":"Hoey","year":"2003","journal-title":"The EMBO Journal"},{"issue":"_2","key":"10.1016\/bs.adgen.2025.11.008_bib66","doi-asserted-by":"crossref","first-page":"14599","DOI":"10.1073\/pnas.0404874101","article-title":"Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines","volume":"101","author":"Hohlfeld","year":"2004","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/bs.adgen.2025.11.008_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.857014","article-title":"The shared mechanism and candidate drugs of multiple sclerosis and Sj\u00f6gren\u2019s syndrome analyzed by bioinformatics based on GWAS and transcriptome data","volume":"13","author":"Hong","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib68","doi-asserted-by":"crossref","DOI":"10.1186\/ar1869","article-title":"Attenuation of murine antigen-induced arthritis by treatment with a decoy oligodeoxynucleotide inhibiting signal transducer and activator of transcription-1 (STAT-1)","volume":"8","author":"H\u00fcckel","year":"2006","journal-title":"Arthritis Research & Therapy"},{"key":"10.1016\/bs.adgen.2025.11.008_bib69","article-title":"JAK\/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens","volume":"11-2023","author":"Hu","year":"2023","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib70","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: From bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"4","key":"10.1016\/bs.adgen.2025.11.008_bib71","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.4049\/jimmunol.1701199","article-title":"Effector T cell resistance to suppression and STAT3 signaling during the development of human type 1 diabetes","volume":"201","author":"Ihantola","year":"2018","journal-title":"The Journal of Immunology"},{"issue":"6460","key":"10.1016\/bs.adgen.2025.11.008_bib72","article-title":"Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility","volume":"365","year":"2019","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.adgen.2025.11.008_bib73","doi-asserted-by":"crossref","DOI":"10.1007\/s40257-025-00946-8","article-title":"JAK inhibitors and inflammatory nail disorders: A systematic review of clinical outcomes and therapeutic potential","author":"Iorizzo","year":"2025","journal-title":"American Journal of Clinical Dermatology"},{"issue":"2","key":"10.1016\/bs.adgen.2025.11.008_bib74","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ajhg.2010.01.017","article-title":"Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene","volume":"86","author":"Jakkula","year":"2010","journal-title":"The American Journal of Human Genetics"},{"issue":"48","key":"10.1016\/bs.adgen.2025.11.008_bib75","doi-asserted-by":"crossref","first-page":"33155","DOI":"10.1074\/jbc.M805138200","article-title":"Nuclear protein tyrosine phosphatase Shp-2 is one important negative regulator of nuclear export of telomerase reverse transcriptase","volume":"283","author":"Jakob","year":"2008","journal-title":"Journal of Biological Chemistry"},{"issue":"7","key":"10.1016\/bs.adgen.2025.11.008_bib76","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1080\/1744666X.2021.1925541","article-title":"JAK inhibitors, psoriatic arthritis, and axial spondyloarthritis: A critical review of clinical trials","volume":"17","author":"Keeling","year":"2021","journal-title":"Expert Review of Clinical Immunology"},{"issue":"13","key":"10.1016\/bs.adgen.2025.11.008_bib77","doi-asserted-by":"crossref","DOI":"10.1172\/JCI164637","article-title":"iPSC-derived reactive astrocytes from patients with multiple sclerosis protect cocultured neurons in inflammatory conditions","volume":"133","author":"Kerkering","year":"2023","journal-title":"The Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib78","doi-asserted-by":"crossref","first-page":"43","DOI":"10.62347\/DMJC6311","article-title":"IFN-\u03b3, IL-17, IL-22+ CD4+ subset in patients with hepatitis C virus and correlation with clinical factor","volume":"13","author":"Khansalar","year":"2024","journal-title":"American Journal of Clinical and Experimental Immunology"},{"issue":"4","key":"10.1016\/bs.adgen.2025.11.008_bib79","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/24755303231201336","article-title":"Deucravacitinib: A novel TYK2 inhibitor for the treatment of moderate-to-severe psoriasis","volume":"8","author":"Kingston","year":"2023","journal-title":"Journal of Psoriasis and Psoriatic Arthritis"},{"key":"10.1016\/bs.adgen.2025.11.008_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.ard.2025.05.023","article-title":"Highly selective tyrosine kinase 2 inhibition with zasocitinib (TAK-279) improves outcomes in patients with active psoriatic arthritis: A randomised phase 2b study","author":"Kivitz","year":"2025","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"12","key":"10.1016\/bs.adgen.2025.11.008_bib81","first-page":"2244","article-title":"Examining the safety profile of Janus Kinase (JAK) inhibitors in the management of immune-mediated diseases: A comprehensive review","volume":"13","author":"Kraev","year":"2023","journal-title":"Life (Chicago, Ill.: 1978)"},{"key":"10.1016\/bs.adgen.2025.11.008_bib82","doi-asserted-by":"crossref","unstructured":"Manna, S. La., Benedictis, I. De., & Marasco, D. Proteomimetics of natural regulators of JAK\u2013STAT pathway: Novel therapeutic perspectives Frontiers in Molecular Biosciences 8-2021, 2022. https:\/\/www.frontiersin.org\/journals\/molecular-biosciences\/articles\/10.3389\/fmolb.2021.792546.","DOI":"10.3389\/fmolb.2021.792546"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib83","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1196\/annals.1447.013","article-title":"STAT4 polymorphism is associated with early-onset type 1 diabetes, but not with late-onset type 1 diabetes","volume":"1150","author":"Lee","year":"2008","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"2","key":"10.1016\/bs.adgen.2025.11.008_bib84","article-title":"STAT4 rs7574865 polymorphism contributes to the risk of type 1 diabetes: A meta analysis","volume":"8","author":"Li","year":"2015","journal-title":"International Journal of Clinical and Experimental Medicine"},{"key":"10.1016\/bs.adgen.2025.11.008_bib85","series-title":"Biomolecules","article-title":"The role of JAK\/STAT pathway in fibrotic diseases: Molecular and cellular mechanisms","author":"Liu","year":"2023"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib86","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13072-022-00456-5","article-title":"3DFAACTS-SNP: Using regulatory T cell-specific epigenomics data to uncover candidate mechanisms of type 1 diabetes (T1D) risk","volume":"15","author":"Liu","year":"2022","journal-title":"Epigenetics & Chromatin"},{"issue":"19","key":"10.1016\/bs.adgen.2025.11.008_bib87","doi-asserted-by":"crossref","first-page":"8831","DOI":"10.1073\/pnas.92.19.8831","article-title":"Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue","volume":"92","author":"Liu","year":"1995","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"10.1016\/bs.adgen.2025.11.008_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102154","article-title":"STAT6-targeting antisense oligonucleotides against solitary fibrous tumor","volume":"35","author":"Li","year":"2024","journal-title":"Molecular Therapy - Nucleic Acids"},{"issue":"9","key":"10.1016\/bs.adgen.2025.11.008_bib89","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nm.3933","article-title":"Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases","volume":"21","author":"Li","year":"2015","journal-title":"Nature Medicine"},{"issue":"4","key":"10.1016\/bs.adgen.2025.11.008_bib90","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","article-title":"Defining the clinical course of multiple sclerosis: Results of an international survey","volume":"46","author":"Lublin","year":"1996","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/bs.adgen.2025.11.008_bib91","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/01902140903144138","article-title":"Decoy oligodeoxynucleotide against STAT transcription factors decreases allergic inflammation in a rat asthma model","volume":"36","author":"L\u00fchrmann","year":"2010","journal-title":"Experimental Lung Research"},{"issue":"16","key":"10.1016\/bs.adgen.2025.11.008_bib92","doi-asserted-by":"crossref","first-page":"8946","DOI":"10.3390\/ijms22168946","article-title":"Th17-Related cytokines as potential discriminatory markers between neuromyelitis optica (Devic\u2019s disease) and multiple sclerosis\u2014A review","volume":"22","author":"Maciak","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib93","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12964-023-01240-y","article-title":"Double-edged sword of JAK\/STAT signaling pathway in viral infections: novel insights into virotherapy","volume":"21","author":"Mahjoor","year":"2023","journal-title":"Cell Communication and Signaling"},{"issue":"17","key":"10.1016\/bs.adgen.2025.11.008_bib94","doi-asserted-by":"crossref","DOI":"10.1172\/JCI138230","article-title":"T Cell protein tyrosine phosphatase protects intestinal barrier function by restricting epithelial tight junction remodeling","volume":"131","author":"Marchelletta","year":"2021","journal-title":"The Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/bs.adgen.2025.11.008_bib95","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ni1052","article-title":"The STAT3 isoforms \u03b1 and \u03b2 have unique and specific functions","volume":"5","author":"Maritano","year":"2004","journal-title":"Nature Immunology"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib96","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13073-018-0604-8","article-title":"Meta-analysis of Immunochip data of four autoimmune diseases reveals novel single-disease and cross-phenotype associations","volume":"10","author":"M\u00e1rquez","year":"2018","journal-title":"Genome Medicine"},{"issue":"11","key":"10.1016\/bs.adgen.2025.11.008_bib97","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.2337\/db15-0362","article-title":"TYK2, a candidate gene for type 1 diabetes, modulates apoptosis and the innate immune response in human pancreatic \u03b2-cells","volume":"64","author":"Marroqui","year":"2015","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/bs.adgen.2025.11.008_bib98","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.2337\/db13-1443","article-title":"BACH2, a candidate risk gene for type 1 diabetes, regulates apoptosis in pancreatic \u03b2-cells via JNK1 modulation and crosstalk with the candidate gene PTPN2","volume":"63","author":"Marroqu\u00ed","year":"2014","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib99","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0016-5085(92)91819-P","article-title":"Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue\u2019)","volume":"102","author":"Marsh","year":"1992","journal-title":"Gastroenterology"},{"issue":"10302","key":"10.1016\/bs.adgen.2025.11.008_bib100","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(21)00438-4","article-title":"Current and future status of JAK inhibitors","volume":"398","author":"McLornan","year":"2021","journal-title":"The Lancet"},{"issue":"3","key":"10.1016\/bs.adgen.2025.11.008_bib101","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0092-8674(00)81288-X","article-title":"Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK\u2013STAT signaling pathway","volume":"84","author":"Meraz","year":"1996","journal-title":"Cell"},{"issue":"4","key":"10.1016\/bs.adgen.2025.11.008_bib102","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/ejhg.2009.195","article-title":"A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis","volume":"18","author":"Mero","year":"2010","journal-title":"European Journal of Human Genetics"},{"issue":"8","key":"10.1016\/bs.adgen.2025.11.008_bib103","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrd4088","article-title":"Therapeutic modulators of STAT signalling for human diseases","volume":"12","author":"Miklossy","year":"2013","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib104","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/s41467-024-45573-9","article-title":"TYK2 signaling promotes the development of autoreactive CD8+ cytotoxic T lymphocytes and type 1 diabetes","volume":"15","author":"Mine","year":"2024","journal-title":"Nature Communications"},{"issue":"5","key":"10.1016\/bs.adgen.2025.11.008_bib105","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.abd.2023.03.001","article-title":"JAK-STAT pathway inhibitors in dermatology","volume":"98","author":"Miot","year":"2023","journal-title":"Anais Brasileiros de Dermatologia"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib106","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13688","article-title":"Upadacitinib: Mechanism of action, clinical, and translational science","volume":"17","author":"Mohamed","year":"2024","journal-title":"Clinical and Translational Science"},{"issue":"8","key":"10.1016\/bs.adgen.2025.11.008_bib107","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/gut.2003.030551","article-title":"Regulation of the T helper cell type 1 transcription factor T-bet in coeliac disease mucosa","volume":"53","author":"Monteleone","year":"2004","journal-title":"Gut"},{"issue":"6","key":"10.1016\/bs.adgen.2025.11.008_bib108","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2337\/db08-1510","article-title":"PTPN2, a candidate gene for type 1 diabetes, modulates interferon-\u03b3\u2013induced pancreatic \u03b2-cell apoptosis","volume":"58","author":"Moore","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/bs.adgen.2025.11.008_bib109","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1393799","article-title":"SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation","volume":"15","author":"Morelli","year":"2024","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"10.1016\/bs.adgen.2025.11.008_bib110","doi-asserted-by":"crossref","DOI":"10.1128\/MMBR.00155-20","article-title":"The CD8+ T cell noncytotoxic antiviral responses","volume":"85","author":"Morvan","year":"2021","journal-title":"Microbiology and Molecular Biology Reviews"},{"issue":"6","key":"10.1016\/bs.adgen.2025.11.008_bib111","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s40262-022-01129-y","article-title":"Filgotinib: A clinical pharmacology review","volume":"61","author":"Namour","year":"2022","journal-title":"Clinical Pharmacokinetics"},{"issue":"9","key":"10.1016\/bs.adgen.2025.11.008_bib112","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/tra.12181","article-title":"Cytokine\u2010induced slowing of STAT3 nuclear import; faster basal trafficking of the STAT3\u03b2 isoform","volume":"15","author":"Ng","year":"2014","journal-title":"Traffic (Copenhagen, Denmark)"},{"key":"10.1016\/bs.adgen.2025.11.008_bib113","series-title":"Cells","article-title":"The role of inflammation in cancer: Mechanisms of tumor initiation, progression, and metastasis","author":"Nishida","year":"2025"},{"issue":"4","key":"10.1016\/bs.adgen.2025.11.008_bib114","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/ng.3245","article-title":"Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers","volume":"47","author":"Onengut-Gumuscu","year":"2015","journal-title":"Nature Genetics"},{"issue":"2","key":"10.1016\/bs.adgen.2025.11.008_bib115","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3390\/ijms26020749","article-title":"Understanding the intricate pathophysiology of psoriasis and related skin disorders","volume":"26","author":"Orzan","year":"2025","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib116","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-med-051113-024537","article-title":"The JAK-STAT pathway: Impact on human disease and therapeutic intervention","volume":"66","author":"O\u2019Shea","year":"2015","journal-title":"Annual Review of Medicine"},{"key":"10.1016\/bs.adgen.2025.11.008_bib117","doi-asserted-by":"crossref","DOI":"10.55563\/clinexprheumatol\/eeglsa","article-title":"Brepocitinib, a potent and selective TYK2\/JAK1 inhibitor: scientific and clinical rationale for dermatomyositis","author":"Paik","year":"2024","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1016\/bs.adgen.2025.11.008_bib118","article-title":"SOCS-JAK-STAT inhibitors and SOCS mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis","volume":"14-2023","author":"Pandey","year":"2023","journal-title":"Frontiers in Immunology"},{"issue":"14","key":"10.1016\/bs.adgen.2025.11.008_bib119","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJMoa1806382","article-title":"Phase 2 trial of selective tyrosine kinase 2 inhibition in psoriasis","volume":"379","author":"Papp","year":"2018","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/bs.adgen.2025.11.008_bib120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02879","article-title":"The C-terminal transactivation domain of STAT1 has a gene-specific role in transactivation and cofactor recruitment","volume":"9","author":"Parrini","year":"2018","journal-title":"Frontiers in Immunology"},{"issue":"6","key":"10.1016\/bs.adgen.2025.11.008_bib121","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/ana.22609","article-title":"Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci","volume":"70","author":"Patsopoulos","year":"2011","journal-title":"Annals of Neurology"},{"issue":"13","key":"10.1016\/bs.adgen.2025.11.008_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111439","article-title":"Cytokine responsive networks in human colonic epithelial organoids unveil a molecular classification of inflammatory bowel disease","volume":"40","author":"Pavlidis","year":"2022","journal-title":"Cell Reports"},{"issue":"6","key":"10.1016\/bs.adgen.2025.11.008_bib123","doi-asserted-by":"crossref","first-page":"899","DOI":"10.4093\/dmj.2020.0194","article-title":"The rs2304256 polymorphism in TYK2 gene is associated with protection for type 1 diabetes mellitus","volume":"45","author":"Pellenz","year":"2021","journal-title":"Diabetes & Metabolism Journal"},{"issue":"2","key":"10.1016\/bs.adgen.2025.11.008_bib124","doi-asserted-by":"crossref","DOI":"10.1590\/1678-4685-gmb-2020-0425","article-title":"Association of TYK2 polymorphisms with autoimmune diseases: A comprehensive and updated systematic review with meta-analysis","volume":"44","author":"Pellenz","year":"2021","journal-title":"Genetics and Molecular Biology"},{"issue":"21","key":"10.1016\/bs.adgen.2025.11.008_bib125","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1016\/j.cell.2022.09.023","article-title":"The JAK-STAT pathway at 30: Much learned, much more to do","volume":"185","author":"Philips","year":"2022","journal-title":"Cell"},{"issue":"8","key":"10.1016\/bs.adgen.2025.11.008_bib126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002216","article-title":"Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases","volume":"7","author":"Plagnol","year":"2011","journal-title":"PLoS Genetics"},{"issue":"3","key":"10.1016\/bs.adgen.2025.11.008_bib127","first-page":"271","article-title":"A review of antisense therapeutic interventions for molecular biological targets in asthma","volume":"1","author":"Popescu","year":"2007","journal-title":"Biologics: Targets & Therapy"},{"issue":"8","key":"10.1016\/bs.adgen.2025.11.008_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109602","article-title":"ZEB1 promotes pathogenic Th1 and Th17 cell differentiation in multiple sclerosis","volume":"36","author":"Qian","year":"2021","journal-title":"Cell Reports"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib129","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jneuroim.2013.04.022","article-title":"The influence of non-HLA gene polymorphisms and interactions on disease risk in a Western Australian multiple sclerosis cohort","volume":"261","author":"Qiu","year":"2013","journal-title":"Journal of Neuroimmunology"},{"issue":"3","key":"10.1016\/bs.adgen.2025.11.008_bib130","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0167-4889(02)00322-1","article-title":"Role of the SHP-2 tyrosine phosphatase in cytokine-induced signaling and cellular response","volume":"1592","author":"Qu","year":"2002","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"10.1016\/bs.adgen.2025.11.008_bib131","article-title":"JAK\/STAT signaling: Molecular targets, therapeutic opportunities, and limitations of targeted inhibitions in solid malignancies","volume":"13-2022","author":"Rah","year":"2022","journal-title":"Frontiers in Pharmacology"},{"issue":"45","key":"10.1016\/bs.adgen.2025.11.008_bib132","doi-asserted-by":"crossref","first-page":"32507","DOI":"10.1074\/jbc.274.45.32507","article-title":"Catalytically active TYK2 is essential for interferon-\u03b2-mediated phosphorylation of STAT3 and interferon-\u03b1 receptor-1 (IFNAR-1) but not for activation of phosphoinositol 3-Kinase","volume":"274","author":"Rani","year":"1999","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib133","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s40425-018-0436-5","article-title":"STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: Results of a phase 1b trial","volume":"6","author":"Reilley","year":"2018","journal-title":"Journal for Immunotherapy of Cancer"},{"issue":"10","key":"10.1016\/bs.adgen.2025.11.008_bib134","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa073003","article-title":"STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus","volume":"357","author":"Remmers","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1016\/bs.adgen.2025.11.008_bib135","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/s41588-021-00880-5","article-title":"Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes","volume":"53","author":"Robertson","year":"2021","journal-title":"Nature Genetics"},{"issue":"8","key":"10.1016\/bs.adgen.2025.11.008_bib136","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1007\/s00125-023-05908-5","article-title":"Inhibition of the type 1 diabetes candidate gene PTPN2 aggravates TNF-\u03b1-induced human beta cell dysfunction and death","volume":"66","author":"Roca-Rivada","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/bs.adgen.2025.11.008_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106642","article-title":"Deucravacitinib is an allosteric TYK2 protein kinase inhibitor FDA-approved for the treatment of psoriasis","volume":"189","author":"Roskoski","year":"2023","journal-title":"Pharmacological Research"},{"issue":"8","key":"10.1016\/bs.adgen.2025.11.008_bib138","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.3390\/cells10081860","article-title":"Tuning monocytes and macrophages for personalized therapy and diagnostic challenge in rheumatoid arthritis","volume":"10","author":"Roszkowski","year":"2021","journal-title":"Cells"},{"issue":"11","key":"10.1016\/bs.adgen.2025.11.008_bib139","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.3390\/cancers12113132","article-title":"Ruxolitinib-associated infections in polycythemia vera: Review of the literature, clinical significance, and recommendations","volume":"12","author":"Sadjadian","year":"2020","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/bs.adgen.2025.11.008_bib140","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","article-title":"A cross-population atlas of genetic associations for 220 human phenotypes","volume":"53","author":"Sakaue","year":"2021","journal-title":"Nature Genetics"},{"issue":"3","key":"10.1016\/bs.adgen.2025.11.008_bib141","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s13555-023-00892-5","article-title":"A review on the safety of using JAK inhibitors in dermatology: Clinical and laboratory monitoring","volume":"13","author":"Samuel","year":"2023","journal-title":"Dermatology and Therapy"},{"issue":"10","key":"10.1016\/bs.adgen.2025.11.008_bib142","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/j.cgh.2022.12.029","article-title":"Oral ritlecitinib and brepocitinib for moderate-to-severe ulcerative colitis: Results from a randomized, phase 2B study","volume":"21","author":"Sandborn","year":"2023","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"12","key":"10.1016\/bs.adgen.2025.11.008_bib143","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.2337\/db11-0758","article-title":"PTPN2, a candidate gene for type 1 diabetes, modulates pancreatic \u03b2-cell apoptosis via regulation of the BH3-only protein bim","volume":"60","author":"Santin","year":"2011","journal-title":"Diabetes"},{"issue":"24","key":"10.1016\/bs.adgen.2025.11.008_bib144","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1038\/s41388-021-01841-2","article-title":"Receptor tyrosine kinases and cancer: Oncogenic mechanisms and therapeutic approaches","volume":"40","author":"Saraon","year":"2021","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib145","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s43556-023-00151-1","article-title":"JAK-STAT signaling in inflammation and stress-related diseases: Implications for therapeutic interventions","volume":"4","author":"Sarapultsev","year":"2023","journal-title":"Molecular Biomedicine"},{"issue":"7359","key":"10.1016\/bs.adgen.2025.11.008_bib146","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature10251","article-title":"Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis","volume":"476","author":"Sawcer","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib147","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12964-017-0177-y","article-title":"The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells","volume":"15","author":"Seif","year":"2017","journal-title":"Cell Communication and Signaling"},{"issue":"4","key":"10.1016\/bs.adgen.2025.11.008_bib148","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4161\/jkst.22312","article-title":"Nucleic acid-based approaches to STAT inhibition","volume":"1","author":"Sen","year":"2012","journal-title":"JAK-STAT"},{"issue":"10","key":"10.1016\/bs.adgen.2025.11.008_bib149","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1016\/j.apsb.2023.07.026","article-title":"JAK inhibition ameliorated experimental autoimmune encephalomyelitis by blocking GM-CSF-driven inflammatory signature of monocytes","volume":"13","author":"Shao","year":"2023","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"5","key":"10.1016\/bs.adgen.2025.11.008_bib150","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3390\/pharmaceutics14051001","article-title":"A comprehensive overview of globally approved JAK inhibitors","volume":"14","author":"Shawky","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.adgen.2025.11.008_bib151","doi-asserted-by":"crossref","DOI":"10.1093\/humrep\/deaf062","article-title":"The phenotypic and genetic association between endometriosis and immunological diseases","author":"Shigesi","year":"2025","journal-title":"Human Reproduction, deaf062"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib152","doi-asserted-by":"crossref","first-page":"56","DOI":"10.22543\/7674.91.P5677","article-title":"Inflammatory bowel disease: Pathogenesis, diagnosis and current therapeutic approach","volume":"9","author":"Silaghi","year":"2022","journal-title":"Journal of Mind and Medical Sciences"},{"issue":"6","key":"10.1016\/bs.adgen.2025.11.008_bib153","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0960-9822(02)00697-8","article-title":"The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3","volume":"12","author":"Simoncic","year":"2002","journal-title":"Current Biology"},{"issue":"5","key":"10.1016\/bs.adgen.2025.11.008_bib154","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.3390\/ijms23052505","article-title":"Type I interferons in systemic lupus erythematosus: A journey from bench to bedside","volume":"23","author":"Sim","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"11","key":"10.1016\/bs.adgen.2025.11.008_bib155","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1158\/2159-8290.CD-23-0383","article-title":"SHP2: A pleiotropic target at the interface of cancer and its microenvironment","volume":"13","author":"Sodir","year":"2023","journal-title":"Cancer Discovery"},{"key":"10.1016\/bs.adgen.2025.11.008_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/0016-5085(93)90912-V","article-title":"HLA susceptibility genes in celiac disease: Genetic mapping and role in pathogenesis","volume":"105","author":"Sollid","year":"1993","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/bs.adgen.2025.11.008_bib157","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15092485","article-title":"The role of STATs in ovarian cancer: Exploring their potential for therapy","volume":"15","author":"Standing","year":"2023","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/bs.adgen.2025.11.008_bib158","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1186\/ar2698","article-title":"Replication of recently identified systemic lupus erythematosus genetic associations: A case\u2013control study","volume":"11","author":"Suarez-Gestal","year":"2009","journal-title":"Arthritis Research & Therapy"},{"key":"10.1016\/bs.adgen.2025.11.008_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105734","article-title":"Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in mice","volume":"117","author":"Syed","year":"2025","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/bs.adgen.2025.11.008_bib160","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0092-8674(00)80702-3","article-title":"A novel transcription factor, T-bet, Directs Th1 lineage commitment","volume":"100","author":"Szabo","year":"2000","journal-title":"Cell"},{"issue":"3","key":"10.1016\/bs.adgen.2025.11.008_bib161","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41584-024-01085-w","article-title":"Efficacy and safety of JAK inhibitors in rheumatoid arthritis: Update for the practising clinician","volume":"20","author":"Szekanecz","year":"2024","journal-title":"Nature Reviews Rheumatology"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib162","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13424","article-title":"Expression of STAT\u2010 and T\u2010cell\u2010related genes in women with first\u2010line treatment of relapsing\u2010remitting multiple sclerosis","volume":"101","author":"Szewczak","year":"2025","journal-title":"Scandinavian Journal of Immunology"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib163","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13424","article-title":"Expression of STAT- and T-cell-related genes in women with first-line treatment of relapsing-remitting multiple sclerosis","volume":"101","author":"Szewczak","year":"2025","journal-title":"Scandinavian Journal of Immunology"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib164","doi-asserted-by":"crossref","DOI":"10.3390\/ph15010030","article-title":"Molecular modeling insights into upadacitinib selectivity upon binding to JAK protein family","volume":"15","author":"Taldaev","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/bs.adgen.2025.11.008_bib165","doi-asserted-by":"crossref","DOI":"10.1038\/s41584-021-00726-8","article-title":"Janus kinase-targeting therapies in rheumatology: A mechanisms-based approach","volume":"18","author":"Tanaka","year":"2022","journal-title":"Nature Reviews Rheumatology"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib166","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1038\/s41467-023-42714-4","article-title":"Rational design of a JAK1-selective siRNA inhibitor for the modulation of autoimmunity in the skin","volume":"14","author":"Tang","year":"2023","journal-title":"Nature Communications"},{"issue":"16","key":"10.1016\/bs.adgen.2025.11.008_bib167","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1128\/MCB.22.16.5662-5668.2002","article-title":"Identification of a nuclear Stat1 protein tyrosine phosphatase","volume":"22","author":"ten Hoeve","year":"2002","journal-title":"Molecular and Cellular Biology"},{"issue":"7","key":"10.1016\/bs.adgen.2025.11.008_bib168","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/ng.396","article-title":"Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20","volume":"41","author":"The Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene)","year":"2009","journal-title":"Nature Genetics"},{"issue":"7","key":"10.1016\/bs.adgen.2025.11.008_bib169","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ng2068","article-title":"Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes","volume":"39","author":"Todd","year":"2007","journal-title":"Nature Genetics"},{"issue":"22","key":"10.1016\/bs.adgen.2025.11.008_bib170","doi-asserted-by":"crossref","first-page":"5384","DOI":"10.3390\/cancers15225384","article-title":"Overcoming immune checkpoint therapy resistance with SHP2 inhibition in cancer and immune cells: A review of the literature and novel combinatorial approaches","volume":"15","author":"Tojjari","year":"2023","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/bs.adgen.2025.11.008_bib171","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1080\/1744666X.2023.2249237","article-title":"JAK inhibitors and black box warnings: What is the future for JAK inhibitors?","volume":"19","author":"Tokareva","year":"2023","journal-title":"Expert Review of Clinical Immunology"},{"issue":"8","key":"10.1016\/bs.adgen.2025.11.008_bib172","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084095","article-title":"STAT1 and its crucial role in the control of viral infections","volume":"23","author":"Tolomeo","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"10.1016\/bs.adgen.2025.11.008_bib173","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4049\/immunohorizons.2000108","article-title":"Potent and selective knockdown of tyrosine kinase 2 by antisense oligonucleotides","volume":"5","author":"Tran","year":"2021","journal-title":"ImmunoHorizons"},{"issue":"12","key":"10.1016\/bs.adgen.2025.11.008_bib174","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/ng.998","article-title":"Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease","volume":"43","author":"Trynka","year":"2011","journal-title":"Nature Genetics"},{"issue":"12","key":"10.1016\/bs.adgen.2025.11.008_bib175","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70094","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral allosteric TYK2 inhibitor ESK\u2010001 using a randomized, double\u2010blind, placebo\u2010controlled study design","volume":"17","author":"Ucpinar","year":"2024","journal-title":"Clinical and Translational Science"},{"issue":"6939","key":"10.1016\/bs.adgen.2025.11.008_bib176","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature01621","article-title":"Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease","volume":"423","author":"Ueda","year":"2003","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib177","article-title":"Gene\u2013environment interactions and their impact on human health","volume":"24","author":"Virolainen","year":"2023","journal-title":"Genes and Immunity"},{"issue":"11","key":"10.1016\/bs.adgen.2025.11.008_bib178","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1002\/art.42547","article-title":"Differences in JAK isoform selectivity among different types of JAK inhibitors evaluated for rheumatic diseases through in vitro profiling","volume":"75","author":"Virtanen","year":"2023","journal-title":"Arthritis & Rheumatology"},{"issue":"10","key":"10.1016\/bs.adgen.2025.11.008_bib179","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41584-024-01153-1","article-title":"JAK inhibitor selectivity: New opportunities, better drugs?","volume":"20","author":"Virtanen","year":"2024","journal-title":"Nature Reviews Rheumatology"},{"issue":"2","key":"10.1016\/bs.adgen.2025.11.008_bib180","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/jgh3.12706","article-title":"Immune\u2010mediated inflammatory diseases of the gastrointestinal tract: Beyond Crohn\u2019s disease and ulcerative colitis","volume":"6","author":"Vuyyuru","year":"2022","journal-title":"JGH Open"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib181","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng.493","article-title":"The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes","volume":"42","author":"Wallace","year":"2010","journal-title":"Nature Genetics"},{"issue":"4","key":"10.1016\/bs.adgen.2025.11.008_bib182","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1182\/blood.V95.4.1249.004k39_1249_1257","article-title":"Targeted disruption of Stat6 DNA binding activity by an oligonucleotide decoy blocks IL-4\u2013driven TH2 cell response","volume":"95","author":"Wang","year":"2000","journal-title":"Blood"},{"key":"10.1016\/bs.adgen.2025.11.008_bib183","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111846","article-title":"Deciphering JAK\/STAT signaling pathway: A multifaceted approach to tumorigenesis, progression and therapeutic interventions","volume":"131","author":"Wang","year":"2024","journal-title":"International Immunopharmacology"},{"key":"10.1016\/bs.adgen.2025.11.008_bib184","article-title":"Identifying shared genetic loci and common risk genes of rheumatoid arthritis associated with three autoimmune diseases based on large-scale cross-trait genome-wide association studies","volume":"14-2023","author":"Wen","year":"2023","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.adgen.2025.11.008_bib185","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152098","article-title":"Genetic, social, and environmental risk factors in rheumatoid arthritis-associated interstitial lung disease","volume":"57","author":"Wheeler","year":"2022","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib186","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/PAP.0000000000000327","article-title":"A pattern-based pathology approach to very early-onset inflammatory bowel disease: Thinking beyond crohn disease and ulcerative colitis","volume":"29","author":"Wilkins","year":"2022","journal-title":"Advances in Anatomic Pathology"},{"key":"10.1016\/bs.adgen.2025.11.008_bib187","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.66014","article-title":"Competitive binding of STATs to receptor phospho-Tyr motifs accounts for altered cytokine responses","volume":"10","author":"Wilmes","year":"2021","journal-title":"ELife"},{"issue":"2","key":"10.1016\/bs.adgen.2025.11.008_bib188","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/annrheumdis-2021-220822","article-title":"Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: A pooled analysis of six phase III clinical trials","volume":"81","author":"Winthrop","year":"2022","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1016\/bs.adgen.2025.11.008_bib189","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3390\/ijms17030406","article-title":"Isolation and expression analysis of STAT members from synechogobius hasta and their roles in leptin affecting lipid metabolism","volume":"17","author":"Wu","year":"2016","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10.1016\/bs.adgen.2025.11.008_bib190","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s13671-023-00412-w","article-title":"JAK inhibitor use for the inpatient dermatologist","volume":"12","author":"Xia","year":"2023","journal-title":"Current Dermatology Reports"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib191","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","article-title":"Evolving cognition of the JAK-STAT signaling pathway: Autoimmune disorders and cancer","volume":"8","author":"Xue","year":"2023","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"6","key":"10.1016\/bs.adgen.2025.11.008_bib192","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s10067-023-06529-4","article-title":"Efficacy and safety of Janus kinase inhibitors in patients with psoriasis and psoriatic arthritis: A systematic review and meta-analysis","volume":"42","author":"Yang","year":"2023","journal-title":"Clinical Rheumatology"},{"issue":"3","key":"10.1016\/bs.adgen.2025.11.008_bib193","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaut.2003.08.006","article-title":"Autoimmune diabetes is blocked in Stat4-deficient mice","volume":"22","author":"Yang","year":"2004","journal-title":"Journal of Autoimmunity"},{"key":"10.1016\/bs.adgen.2025.11.008_bib194","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2024.110988","article-title":"SOCS modulates JAK-STAT pathway as a novel target to mediate the occurrence of neuroinflammation: Molecular details and treatment options","volume":"213","author":"Yan","year":"2024","journal-title":"Brain Research Bulletin"},{"issue":"6","key":"10.1016\/bs.adgen.2025.11.008_bib195","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nri2093","article-title":"SOCS proteins, cytokine signalling and immune regulation","volume":"7","author":"Yoshimura","year":"2007","journal-title":"Nature Reviews. Immunology"},{"issue":"1","key":"10.1016\/bs.adgen.2025.11.008_bib196","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1074\/jbc.275.1.599","article-title":"Cytosolic tyrosine dephosphorylation of STAT5","volume":"275","author":"Yu","year":"2000","journal-title":"Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/bs.adgen.2025.11.008_bib197","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1080\/08820139.2022.2079419","article-title":"The impact of STAT3 rs1053005 variation on type 1 diabetes mellitus susceptibility: Association study and in silico analysis","volume":"51","author":"Zandi","year":"2022","journal-title":"Immunological Investigations"},{"issue":"10","key":"10.1016\/bs.adgen.2025.11.008_bib198","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.humimm.2008.07.004","article-title":"STAT4: # risk factor for type 1 diabetes?","volume":"69","author":"Zervou","year":"2008","journal-title":"Human Immunology"},{"issue":"1\u20132","key":"10.1016\/bs.adgen.2025.11.008_bib199","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0378-1119(97)00446-0","article-title":"Molecular cloning and characterization of P113, a mouse SNF2\/SWI2-related transcription factor","volume":"202","author":"Zhang","year":"1997","journal-title":"Gene"},{"issue":"2","key":"10.1016\/bs.adgen.2025.11.008_bib200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002004","article-title":"Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen Non-HLa shared loci","volume":"7","author":"Zhernakova","year":"2011","journal-title":"PLoS Genetics"}],"container-title":["Advances in Genetics","Genetic Regulation of Immune Response Pathways"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065266025000367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065266025000367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T01:26:27Z","timestamp":1769477187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065266025000367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443473364"],"references-count":200,"URL":"https:\/\/doi.org\/10.1016\/bs.adgen.2025.11.008","relation":{},"ISSN":["0065-2660"],"issn-type":[{"value":"0065-2660","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}